InsidersTradesSigma
Follow the 盘龙药业 share price and the full directors' dealings record of the company, a listed issuer based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 盘龙药业 has recorded 3 insider filings. Market capitalisation: €2.8bn. The latest transaction was filed on 12 March 2026 (Sale). Among the most active insiders: 朱文锋. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
盘龙药业是一家在XSHE市场上市的健康和制药领域的公司。它专注于创新药物的研发和生产。